IQVIA HOLDINGS INC
NYSE: IQV (IQVIA Holdings, Inc.)
Kemas kini terakhir: 9 jam lalu197.27
5.75 (3.00%)
| Penutupan Terdahulu | 191.52 |
| Buka | 191.81 |
| Jumlah Dagangan | 3,345,878 |
| Purata Dagangan (3B) | 1,531,970 |
| Modal Pasaran | 35,804,504,064 |
| Harga / Pendapatan (P/E TTM) | 25.92 |
| Harga / Pendapatan (P/E Ke hadapan) | 16.45 |
| Harga / Jualan (P/S) | 2.37 |
| Harga / Buku (P/B) | 5.14 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Feb 2025 - 17 Feb 2025 |
| Margin Keuntungan | 9.17% |
| Margin Operasi (TTM) | 14.84% |
| EPS Cair (TTM) | 7.83 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 4.30% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -5.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 200.26% |
| Nisbah Semasa (MRQ) | 0.810 |
| Aliran Tunai Operasi (OCF TTM) | 2.58 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 2.00 B |
| Pulangan Atas Aset (ROA TTM) | 5.11% |
| Pulangan Atas Ekuiti (ROE TTM) | 22.00% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Bercampur |
| Diagnostics & Research (Global) | Bercampur | Bercampur | |
| Stok | IQVIA Holdings, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 4.5 |
| Purata Bergerak Teknikal | -5.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.75 |
|
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 0.92% |
| % Dimiliki oleh Institusi | 94.53% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Mitsubishi Ufj Asset Management Co., Ltd. | 30 Sep 2024 | 2,379,300 |
| Cantillon Capital Management Llc | 30 Sep 2024 | 1,840,127 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 276.00 (Redburn Atlantic, 39.91%) | Beli |
| Median | 255.00 (29.26%) | |
| Rendah | 212.00 (Baird, 7.47%) | Pegang |
| Purata | 253.80 (28.66%) | |
| Jumlah | 14 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 207.93 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Stephens & Co. | 20 Dec 2024 | 250.00 (26.73%) | Beli | 197.27 |
| B of A Securities | 13 Dec 2024 | 235.00 (19.13%) | Beli | 199.06 |
| Truist Securities | 12 Dec 2024 | 261.00 (32.31%) | Beli | 200.37 |
| 04 Nov 2024 | 265.00 (34.33%) | Beli | 210.19 | |
| Baird | 11 Dec 2024 | 212.00 (7.47%) | Pegang | 201.07 |
| 01 Nov 2024 | 223.00 (13.04%) | Pegang | 209.16 | |
| RBC Capital | 11 Dec 2024 | 270.00 (36.87%) | Beli | 201.07 |
| 04 Dec 2024 | 270.00 (36.87%) | Beli | 203.17 | |
| Leerink Partners | 19 Nov 2024 | 248.00 (25.72%) | Beli | 191.33 |
| JP Morgan | 05 Nov 2024 | 240.00 (21.66%) | Beli | 212.87 |
| 23 Oct 2024 | 279.00 (41.43%) | Beli | 228.31 | |
| Morgan Stanley | 04 Nov 2024 | 265.00 (34.33%) | Beli | 210.19 |
| BTIG | 01 Nov 2024 | 260.00 (31.80%) | Beli | 209.16 |
| Barclays | 01 Nov 2024 | 255.00 (29.26%) | Beli | 209.16 |
| 15 Oct 2024 | 260.00 (31.80%) | Beli | 232.98 | |
| Deutsche Bank | 01 Nov 2024 | 265.00 (34.33%) | Beli | 209.16 |
| Goldman Sachs | 01 Nov 2024 | 250.00 (26.73%) | Beli | 209.16 |
| TD Cowen | 01 Nov 2024 | 255.00 (29.26%) | Beli | 209.16 |
| Redburn Atlantic | 14 Oct 2024 | 276.00 (39.91%) | Beli | 233.22 |
| Evercore ISI Group | 08 Oct 2024 | 265.00 (34.33%) | Beli | 226.72 |
| Papar semua | ||||
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 06 Nov 2024 | Pengumuman | IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024 |
| 31 Oct 2024 | Pengumuman | IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day |
| 15 Oct 2024 | Pengumuman | IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 |
| 02 Oct 2024 | Pengumuman | IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™ |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |